1 March 2025 false No description of principal activity Taxfiler 2024.6 15526111 business:PrivateLimitedCompanyLtd 2025-03-01 2026-02-28 15526111 2025-02-28 15526111 2025-03-01 2026-02-28 15526111 business:AuditExemptWithAccountantsReport 2025-03-01 2026-02-28 15526111 business:FilletedAccounts 2025-03-01 2026-02-28 15526111 2026-02-28 15526111 business:Director1 2025-03-01 2026-02-28 15526111 business:RegisteredOffice 2025-03-01 2026-02-28 15526111 2025-02-28 15526111 core:WithinOneYear 2026-02-28 15526111 core:WithinOneYear 2025-02-28 15526111 core:ShareCapital core:PreviouslyStatedAmount 2026-02-28 15526111 core:ShareCapital core:PreviouslyStatedAmount 2025-02-28 15526111 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2026-02-28 15526111 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-02-28 15526111 core:PreviouslyStatedAmount 2026-02-28 15526111 core:PreviouslyStatedAmount 2025-02-28 15526111 business:SmallEntities 2025-03-01 2026-02-28 15526111 countries:EnglandWales 2025-03-01 2026-02-28 15526111 core:ComputerEquipment 2025-03-01 2026-02-28 15526111 core:ComputerEquipment 2025-02-28 15526111 core:ComputerEquipment 2026-02-28 15526111 2024-03-01 2025-02-28 iso4217:GBP xbrli:pure
Company Registration No. 15526111 (England and Wales)
Rk Vascular Limited Unaudited accounts for the year ended 28 February 2026
Rk Vascular Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Rk Vascular Limited Company Information for the year ended 28 February 2026
Director
Dr R Kapur
Company Number
15526111 (England and Wales)
Registered Office
Office 8 McMillan House 6 Wolfreton Drive, Anlaby Hull North Humberside HU10 7BY England
Accountants
Westlands Chartered Accountants McMillan House 6 Wolfreton Drive Anlaby East Riding of Yorkshire HU10 7BY
- 3 -
Rk Vascular Limited Statement of financial position as at 28 February 2026
2026
2025
Notes
£
£
Fixed assets
Tangible assets
4
1,200
-
Current assets
Cash at bank and in hand
12,362
17,239
Creditors: amounts falling due within one year
5
(4,841)
(5,842)
Net current assets
7,521
11,397
Net assets
8,721
11,397
Capital and reserves
Called up share capital
1
1
Profit and loss account
8,720
11,396
Shareholders' funds
8,721
11,397
For the year ending 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 6 July 2026 and were signed on its behalf by
Dr R Kapur Director Company Registration No. 15526111
- 4 -
Rk Vascular Limited Notes to the Accounts for the year ended 28 February 2026
1
Statutory information
Rk Vascular Limited is a private company, limited by shares, registered in England and Wales, registration number 15526111. The registered office is Office 8, McMillan House, 6 Wolfreton Drive, Anlaby, Hull, North Humberside, HU10 7BY, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
33% on cost
4
Tangible fixed assets
Computer equipment
£
Cost or valuation
At cost
At 1 March 2025
-
Additions
1,599
At 28 February 2026
1,599
Depreciation
Charge for the year
399
At 28 February 2026
399
Net book value
At 28 February 2026
1,200
- 5 -
Rk Vascular Limited Notes to the Accounts for the year ended 28 February 2026
5
Creditors: amounts falling due within one year
2026
2025
£
£
Taxes and social security
-
2,674
Loans from directors
4,391
2,768
Accruals
450
400
4,841
5,842
6
Transactions with related parties
At the balance sheet date, the company owed Dr R Kapur £4,391 (2025:£2,768), by the way of an interest free loan, the loan is repayable upon demand.
7
Controlling party
The company is under the control of Dr R Kapur, the sole director and shareholder of the company.
8
Average number of employees
During the year the average number of employees was 1 (2025: 1).
- 6 -